longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BURL

BURL
239.5403.83%( +8.830 )

LongbridgeAI

The Market's Leftover Bin: Real Businesses vs. Costly Fantasies

Global Report
Sep 8, 2026 at 09:19 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

From discount retailers to deep-sea mining moonshots, this unclassified group exposes the market's stark divide. While Entegris and Burlington prove their worth, others are just fighting to survive.

Wall Street loves neat little categories, but what happens to the stragglers that get dumped into the "Other" bucket? Grouping a deep-sea mining startup, a discount retailer, and a couple of semiconductor players is absurd, and here's why. It is the perfect litmus test to see who is actually building real businesses in 2026 and who is just taking up space.

Let's start with the companies actually capitalizing on the AI boom. Entegris (ENTG.US) has been trending higher this year, and for good reason—Q2 2026 sales jumped 11.5%. You do not have to be Nvidia to make money off AI hardware. Meanwhile, Cognizant (CTSH.US) is trading sideways. Sure, they announced a massive push in September 2026 to hire 15,000 AI-focused operators, but with Q2 revenue up a meager 4.5%, you have to ask: Why aren't you moving faster?

Over in retail, Burlington Stores (BURL.US) is crushing it. The stock has shown strong momentum recently, printing nearly USD 3B in Q2 net sales and dropping USD 370M to relocate its headquarters to Philly. The discount model is bulletproof right now. On the flip side, Boqii Holding (BQ.US) had to issue a statement addressing unusual trading activity, all while its FY26 first-half revenue shrank. As for Almacenes Exito (ALMU.US) and Yalla Group (YB.US), they remain completely off the radar with virtually no market noise.

The fringe tech and biotech bets are a total mess. 10x Genomics (TXG.US) bounced back recently after winning a USD 4.8M patent infringement verdict in August. Good for them. But look at Tenon Medical (TNON.US)—they reported a miserable EPS in Q2 and pulled off a 1-for-35 reverse stock split just to stay compliant. Good luck with that. And then there is TMC the metals company (TMC.US), hovering at recent lows. They got their deep-sea mining application past NOAA in August 2026, but bleeding over USD 80M in the first half of the year proves that scooping rocks from the ocean floor is a costly fantasy.

Finally, Deep Value ETF (DFDV.US) is just drifting with the broader market. Here is my view: stop dumpster-diving in the unclassified bin. Stick to the ones with actual cash flows like Entegris or Burlington.

This article does not constitute investment advice.

Login to unlock1,716characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Entegris

Entegris

USENTG

+3.43%

Cognizant Tech Solutions

Cognizant Tech Solutions

USCTSH

+0.05%

Burlington Stores

Burlington Stores

USBURL

+3.83%